"A new drug approach has been developed for safer clean-up of deformed blood vessels in the eye by a research team at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto," reports
Science Daily. "Research just published by Dr. Andras Nagy and co-authors shows both safety and effectiveness in their bioengineered compound when treating retinopathy in mice. The therapeutic, which they called 'Sticky-trap,' shuts down tiny deformed blood vessels in the eye without affecting healthy vessels in other sites of the body."
Read more.
No comments:
Post a Comment